Cost-Utility Model of Nirmatrelvir/Ritonavir in Brazil: Analysis of a Vaccinated Population.

Fernandes, Ricardo R A; Barros, Bruno M; da Costa, Milene R; Magliano, Carlos A S; Tura, Bernardo R; Morais, Quenia Cristina D; Santos, Marisa

Fernandes, Ricardo R A; Barros, Bruno M; da Costa, Milene R; Magliano, Carlos A S; Tura, Bernardo R; Morais, Quenia Cristina D; Santos, Marisa.

Afiliación

Fernandes RRA; National Cardiology Institute, Rio de Janeiro, Brazil. Electronic address: ricardorafernandes@gmail.com.
Barros BM; National Cardiology Institute, Rio de Janeiro, Brazil.
da Costa MR; National Cardiology Institute, Rio de Janeiro, Brazil; Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Magliano CAS; National Cardiology Institute, Rio de Janeiro, Brazil.
Tura BR; National Cardiology Institute, Rio de Janeiro, Brazil.
Morais QCD; National Cardiology Institute, Rio de Janeiro, Brazil.
Santos M; National Cardiology Institute, Rio de Janeiro, Brazil.

Value Health Reg Issues ; 40: 74-80, 2024 Mar.

Article en En | MEDLINE | ID: mdl-37995417

Asunto(s)

COVID-19; Lactamas; Leucina; Nitrilos; Prolina; Ritonavir; Adulto; Humanos; Persona de Mediana Edad; Anciano; Ritonavir/uso terapéutico; Brasil; Vacunas contra la COVID-19/uso terapéutico; COVID-19/prevención & control

Palabras clave

COVID-19; cost-effectiveness; cost-utility; nirmatrelvir; ritonavir

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prolina / Ritonavir / COVID-19 / Lactamas / Leucina / Nitrilos Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: America do sul / Brasil Idioma: En Revista: Value Health Reg Issues Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google